Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.

Gómez-Cañas, M

Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile. [electronic resource] - Pharmacological research 08 2016 - 205-215 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1096-1186

10.1016/j.phrs.2016.03.021 doi


Animals
Binding Sites
Blood-Brain Barrier--metabolism
Brain--drug effects
Brain Injuries--drug therapy
Cannabinoid Receptor Agonists--chemical synthesis
Cell Line
Disease Models, Animal
Humans
Isoxazoles--chemical synthesis
Male
Malonates
Mice
Models, Biological
Nerve Degeneration
Neurons--drug effects
Neuroprotective Agents--chemical synthesis
Permeability
Protein Binding
Rats, Wistar
Receptor, Cannabinoid, CB2--agonists
Transfection